CRA developed economic analyses to determine damages in a patent infringement case involving a pharmaceutical product used for the treatment of congestive heart failure and skinny labeling by a generic competitor. CRA provided an initial report on economic damages calculating lost profits and reasonable royalties as well as deposition and trial testimony.
CRA expands its Intellectual Property Practice
CRA has expanded its Intellectual Property Practice with the addition of 20 consultants including Chris Bakewell and Julia Rowe, who have joined the firm as...